Adam

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC)

Update to information on psychiatric disorders for chloroquine and hydroxychloroquine EMA’s safety committee (PRAC) has recommended updating the product information for all chloroquine or hydroxychloroquine-containing medicines following a review of all available data that confirmed a link between the use of these medicines and the risk of psychiatric disorders and suicidal behaviour.

Commission adopts Action Plan on Intellectual Property to strengthen EU’s economic resilience and recovery

Today, the Commission published a new Action Plan on Intellectual Property to help companies, especially small and medium-sized companies (SMEs), to make the most of their inventions and creations and ensure they can benefit our economy and society.

Italy: EIB and Italian Ministry of Justice join forces to promote social inclusion of convicts through a social impact bond

The project aims to curb the reoffending rate of ex-convicts and ensure smooth reintegration into society EIB experts will work with the Italian Ministry of Justice to assess the possibility to launch a social impact bond The geographical focus of this agreement is limited to the Lombardy Region, but bears the potential to be adopted […]